| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | GLURZ1; GRIN1; NMD-R1; NMDZ1; NMZ1 |
| Entrez GeneID | 2902; |
| WB Predicted band size | 120kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | Peptide sequence around aa.894~898 (R-R-S-S-K) derived from Human NMDAR1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于NMDAR1(Ab-896)抗体的部分参考文献示例(内容基于假设性文献，仅供参考)：
---
1. **文献名称**：*Specificity and Application of Anti-NMDAR1 (Ab-896) Antibody in Rodent Brain Studies*
**作者**：Smith A, et al.
**摘要**：本研究验证了NMDAR1(Ab-896)抗体在小鼠和大鼠脑组织中的特异性，通过Western blot检测到约120 kDa的目标条带，并成功应用于免疫组化实验，证实其在海马和皮层神经元中的定位。
2. **文献名称**：*Role of NMDAR1 in Ischemic Brain Injury: Insights from Antibody-Based Blockade*
**作者**：Chen L, et al.
**摘要**：利用NMDAR1(Ab-896)抗体阻断受体功能，研究显示其显著减轻了缺血再灌注损伤模型的神经元死亡，提示NMDAR1在脑缺血病理中的关键作用。
3. **文献名称**：*Validation of Commercial NMDAR1 Antibodies for Neurodegenerative Disease Research*
**作者**：Johnson R, et al.
**摘要**：系统性评估了包括Ab-896在内的多种NMDAR1抗体，证明其在阿尔茨海默病模型脑脊液及组织中具有高灵敏度和特异性，支持其用于疾病生物标志物研究。
---
**注意**：以上为假设性文献，实际文献需通过PubMed、Google Scholar等平台检索关键词“NMDAR1 Ab-896 antibody”或查阅抗体供应商(如CST、Abcam)提供的引用文献列表获取。若需具体论文，建议提供更详细的抗体信息或研究背景进一步筛选。
The NMDAR1 (Ab-896) antibody is a widely used tool in neuroscience research, targeting the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor, a critical ionotropic glutamate receptor in the central nervous system. The NMDA receptor, composed of NR1 and NR2/NR3 subunits, plays a central role in synaptic plasticity, learning, and memory. The NR1 subunit is essential for receptor function, forming the core channel structure and binding sites for co-agonists like glycine. The Ab-896 antibody specifically recognizes an epitope within the C-terminal region of the NR1 subunit, enabling detection of endogenous protein expression across various applications, including Western blotting, immunohistochemistry, and immunoprecipitation.
Developed in rabbit as a monoclonal antibody, Ab-896 has been validated for specificity in multiple species, including human, mouse, and rat tissues. Its utility extends to studies of neurological and psychiatric disorders, such as Alzheimer’s disease, schizophrenia, and epilepsy, where dysregulation of NMDA receptor signaling is implicated. Researchers also employ this antibody to investigate synaptic protein localization, receptor trafficking, and post-translational modifications under physiological or pathological conditions. Proper controls, such as knockout validations or peptide blocking, are recommended to confirm signal specificity due to potential cross-reactivity with related proteins. Overall, Ab-896 remains a key reagent for unraveling NMDA receptor biology and its role in brain function and disease.
×
